252 related articles for article (PubMed ID: 12847108)
21. CD28 stimulates tyrosine phosphorylation, cellular redistribution and catalytic activity of the inositol lipid 5-phosphatase SHIP.
Edmunds C; Parry RV; Burgess SJ; Reaves B; Ward SG
Eur J Immunol; 1999 Nov; 29(11):3507-15. PubMed ID: 10556805
[TBL] [Abstract][Full Text] [Related]
22. TPIP: a novel phosphoinositide 3-phosphatase.
Walker SM; Downes CP; Leslie NR
Biochem J; 2001 Dec; 360(Pt 2):277-83. PubMed ID: 11716755
[TBL] [Abstract][Full Text] [Related]
23. Metabolic switching of PI3K-dependent lipid signals.
Downes CP; Leslie NR; Batty IH; van der Kaay J
Biochem Soc Trans; 2007 Apr; 35(Pt 2):188-92. PubMed ID: 17371235
[TBL] [Abstract][Full Text] [Related]
24. Phosphatidylinositol 3,4,5-trisphosphate is a substrate for the 75 kDa inositol polyphosphate 5-phosphatase and a novel 5-phosphatase which forms a complex with the p85/p110 form of phosphoinositide 3-kinase.
Jackson SP; Schoenwaelder SM; Matzaris M; Brown S; Mitchell CA
EMBO J; 1995 Sep; 14(18):4490-500. PubMed ID: 7556092
[TBL] [Abstract][Full Text] [Related]
25. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN.
Huang J; Kontos CD
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):745-51. PubMed ID: 12006385
[TBL] [Abstract][Full Text] [Related]
27. PTEN: life as a tumor suppressor.
Simpson L; Parsons R
Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
[TBL] [Abstract][Full Text] [Related]
28. Phosphatidylinositol Kinases and Phosphatases in
Nakada-Tsukui K; Watanabe N; Maehama T; Nozaki T
Front Cell Infect Microbiol; 2019; 9():150. PubMed ID: 31245297
[TBL] [Abstract][Full Text] [Related]
29. Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial.
Seminario MC; Wange RL
Immunol Rev; 2003 Apr; 192():80-97. PubMed ID: 12670397
[TBL] [Abstract][Full Text] [Related]
30. The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation.
Ooms LM; Fedele CG; Astle MV; Ivetac I; Cheung V; Pearson RB; Layton MJ; Forrai A; Nandurkar HH; Mitchell CA
Mol Biol Cell; 2006 Feb; 17(2):607-22. PubMed ID: 16280363
[TBL] [Abstract][Full Text] [Related]
31. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
32. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals.
Scharenberg AM; El-Hillal O; Fruman DA; Beitz LO; Li Z; Lin S; Gout I; Cantley LC; Rawlings DJ; Kinet JP
EMBO J; 1998 Apr; 17(7):1961-72. PubMed ID: 9524119
[TBL] [Abstract][Full Text] [Related]
33. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
Pesesse X; Moreau C; Drayer AL; Woscholski R; Parker P; Erneux C
FEBS Lett; 1998 Oct; 437(3):301-3. PubMed ID: 9824312
[TBL] [Abstract][Full Text] [Related]
34. Acute regulation of the tumour suppressor phosphatase, PTEN, by anionic lipids and reactive oxygen species.
Downes CP; Walker S; McConnachie G; Lindsay Y; Batty IH; Leslie NR
Biochem Soc Trans; 2004 Apr; 32(Pt 2):338-42. PubMed ID: 15046604
[TBL] [Abstract][Full Text] [Related]
35. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
[TBL] [Abstract][Full Text] [Related]
36. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
[TBL] [Abstract][Full Text] [Related]
37. AKT1 and PTEN show the highest affinities among phosphoinositide binding proteins for the second messengers PtdIns(3,4,5)P
Nelson N; Razeto A; Gilardi A; Grättinger M; Kirchmair J; Jücker M
Biochem Biophys Res Commun; 2021 Sep; 568():110-115. PubMed ID: 34214875
[TBL] [Abstract][Full Text] [Related]
38. The role of SHIP in cytokine-induced signaling.
Kalesnikoff J; Sly LM; Hughes MR; Büchse T; Rauh MJ; Cao LP; Lam V; Mui A; Huber M; Krystal G
Rev Physiol Biochem Pharmacol; 2003; 149():87-103. PubMed ID: 12692707
[TBL] [Abstract][Full Text] [Related]
39. A requirement of MAPKAPK2 in the uropod localization of PTEN during FMLP-induced neutrophil chemotaxis.
Wu Y; Hannigan MO; Kotlyarov A; Gaestel M; Wu D; Huang CK
Biochem Biophys Res Commun; 2004 Apr; 316(3):666-72. PubMed ID: 15033451
[TBL] [Abstract][Full Text] [Related]
40. How does SHIP1/2 balance PtdIns(3,4)P2 and does it signal independently of its phosphatase activity?
Xie J; Erneux C; Pirson I
Bioessays; 2013 Aug; 35(8):733-43. PubMed ID: 23650141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
